Abstract:Objectives: To explore mechanisms through which altered peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) expression may influence Alzheimer disease (AD) amyloid neuropathology and to test the hypothesis that promotion of PGC-1 alpha expression in neurons might be developed as a novel therapeutic strategy in AD.Design: Case-control.Patients: Human postmortem brain (hippocampal formation) samples from AD cases and age-matched non-AD cases.Results: Using genome-wide complementary DNA microarray analysis, we found that PGC-1 alpha messenger RNA expression was significantly decreased as a function of progression of clinical dementia in the AD brain. Following confirmatory real-time polymerase chain reaction assay, we continued to explore the role of PGC-1 alpha in clinical dementia and found that PGC-1 alpha protein content was negatively associated with both AD-type neuritic plaque pathology and beta-amyloid (A beta)(X-42) contents. Moreover, we found that the predicted elevation of amyloidogenic A beta(1-42) and A beta(1-40) peptide accumulation in embryonic cortico-hippocampal neurons derived from Tg2576 AD mice under hyperglycemic conditions (glucose level, 182-273 mg/dL) coincided with a dose-dependent attenuation in PGC-1 alpha expression. Most importantly, we found that the reconstitution of exogenous PGC-1 alpha expression in Tg2576 neurons attenuated the hyperglycemic-mediated beta-amyloidogenesis through mechanisms involving the promotion of the "nonamyloidogenic" alpha-secretase processing of amyloid precursor protein through the attenuation of the forkheadlike transcription factor 1 (FoxO3a) expression.Conclusion: Therapeutic preservation of neuronal PGC-1 alpha expression promotes the nonamyloidogenic processing of amyloid precursor protein precluding the generation of amyloidogenic A beta peptides.

The Study on the Role of Transcription Factor GATA Binding Protein 3 in Familial Alzheimer's Disease Pathogenesis

Down‐regulation of Insulin‐degrading Enzyme by Presenilin 1 V97L Mutant Potentially Underlies Increased Levels of Amyloid Beta 42

Mutation Analysis of Presenilin-1 Gene in Alzheimer' S Disease Patients and the Effects of Its Mutation on Expression of Presenilin-1 and Amyloid Precursor Protein

Roles of Glycogen Synthase Kinase 3 in Alzheimer’s Disease

P3‐175: Presenilin‐1 Val97Leu Mutation Induces Hyperphosphorylation of Tau Through Activating Glycogen Synthase Kinase‐3

Genetic Dissection of Glutathione S-transferase Omega-1: Identification of Novel Downstream Targets and Alzheimer’s Disease Pathways

The innate immunity protein IFITM3 modulates -secretase in Alzheimer's disease

Two novel presenilin-1 mutations (I249L and P433S) in early onset Chinese Alzheimer's pedigrees and their functional characterization.

A Novel PSEN1 M139L Mutation Found in a Chinese Pedigree with Early-Onset Alzheimer's Disease Increases Aβ42/Aβ40 Ratio.

Effect of Presenilin Mutations on APP Cleavage; Insights into the Pathogenesis of FAD

A positive feedback inhibition of isocitrate dehydrogenase 3β on paired-box gene 6 promotes Alzheimer-like pathology

Substitution of a Glycogen Synthase Kinase-3β Phosphorylation Site in Presenilin 1 Separates Presenilin Function from β-Catenin Signaling*

Increased EID1 nuclear translocation impairs synaptic plasticity and memory function associated with pathogenesis of Alzheimer's disease

In silico analyses for molecular genetic mechanism and candidate genes in patients with Alzheimer’s disease

Peptide p3 may play a neuroprotective role in the brain.

The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer’s disease

Co-Expression of Three Wild-Type 3R-Tau Isoforms Induces Memory Deficit via Oxidation-Related DNA Damage and Cell Death: A Promising Model for Tauopathies

Regulation of 1, 4, 5-Triphosphate Receptor Channel Gating Dynamics by Mutant Presenilin in Alzheimer’s Disease Cells

Characteristics of Insulin-degrading Enzyme in Alzheimer's Disease: A Meta-Analysis.

Enhancement of Β-Amyloid Oligomer Accumulation after Intracerebroventricular Injection of Streptozotocin, Which Involves Central Insulin Signaling in a Transgenic Mouse Model

Pgc-1 Alpha Expression Decreases In The Alzheimer Disease Brain As A Function Of Dementia